2014 Dec 18
New understanding of macrophage gene regulation could help control cancer
A new database that maps how cells regulate gene expression could provide strategies to stop tumor growth. Read more
2014 Dec 15
Molecular link discovered between prostate and breast cancer, suggesting new treatment approach for men's tumor
Prostate cancer can be driven by the same estrogen receptor responsible for the most common form of breast cancer. Read more
2014 Dec 12
Epigenetics research prompts hope for improved treatment of acute myeloid leukemia
Gail Roboz, director of the Leukemia Program, presented an educational platform discussing the introduction of epigenetic and personalized therapies targeting AML at the ASH Annual Meeting. Read more
2014 Dec 12
Researchers reveal key step in synthesis of DNA at chromosome ends
A new study by Neal Lue and colleagues clarifies how telomeres, the protective caps at the tips of our chromosomes, are made. Read more
2014 Dec 11
How DNA sequencing in sewers could detect disease outbreaks
Christopher Mason, assistant professor of computational and systems biomedicine, is creating a “Pathomap” of germs Read more
2014 Dec 08
Promising results for Lenalidomide-Rituximab treatment in mantle cell lymphoma
Jia Ruan, M.D., Ph.D., talks to OncLive about the results of a phase II study that show sustained remissions experienced by patients treated with the combination of lenalidomide and rituximab as initial treatment for mantle cell lymphoma (MCL). Read more
2014 Nov 21
New study sheds light on prostate cancer development
Researchers have discovered more information about an elusive part of our cells, which could lead to a better understanding of how prostate cancer develops. Read more
2014 Nov 06
Chen-Kiang honored with $600k V Foundation translational grant
Selina Chen-Kiang, Ph.D., was among 12 scientists selected from across the nation to receive a $600,000 award to promote translational cancer research. Read more
2014 Nov 05
Roboz discusses progress, challenges in AML
Gail J. Roboz, M.D., discusses the status of research into acute myeloid leukemia during a presentation at the 2014 Chemotherapy Foundation Symposium. Read more
2014 Oct 20
Cantley elected to the Institute of Medicine of the National Academies
Meyer Cancer Center Director Lewis C. Cantley receives one of the highest honors in the fields of health and medicine Read more
2014 Oct 07
Cancer research breakthrough for WCMC-Qatar
Researchers at Weill Cornell Medical College in Qatar have made a major step towards understanding why certain cancers often recur after they have been treated with conventional therapies. Read more
2014 Oct 02
Liquid biopsy project receives innovation award and funding
David Lyden’s blood test to isolate cancer released exosomes was one of six projects selected as winners of the inaugural Daedalus Fund for Innovation. Read more
2014 Sep 22
Target Practice: Precision approaches are a major advance in the treatment of blood cancers
A feature in Weill Cornell Medicine highlights some of the work being done by John Leonard, Leandro Cerchietti, Ari Melnick and others at the Meyer Cancer Center to tailor treatments to individual patients. Read more
2014 Sep 10
End-of-life care preferences: A promising target for reducing racial disparities in terminal cancer care
Race and ethnicity dramatically influence patients' end-of-life preferences, which affect the likelihood they will complete a do-not-resuscitate order. Read more
2014 Sep 04
The newest precision medicine tool: Prostate cancer organoids
Work by Andrea Shoner and his team has demonstrated that organ tissue derived from human prostate cancer tumors can be grown in the laboratory, giving researchers a new tool to test cancer drugs and personalize cancer treatment. Read more
2014 Sep 02
Donors support recruitment of star researcher
“Once-in-a-generation” researcher John Blenis joins the Meyer Cancer Center team as Anna-Maria and Stephen Kellen Professor of Cancer Research. Read more
2014 Jul 31
Researchers see promise for two new therapies for mantle cell lymphoma
A research team led by Selina Chen-Kiang has revealed key insights into why late resistance to breakthrough drug ibrutinib occurs in many mantle cell lymphoma patients, and has shown preclinical success with two new treatment strategies. Read more
2014 Jun 11
Preventing tongue cancer with a drug combination
Researchers at Weill Cornell Medical College have discovered what they believe may be the first effective drug therapy to prevent tongue cancer, one of the world's most common cancers. Read more
2014 Jun 01
Bench to Bedside
The Cornell Alumni Magazine features director Lewis Cantley and several other Meyer Cancer Center leaders. Read more
2014 May 12
Paying it forward: Breakthrough Prize winners support next generation of scientists
Meyer Cancer Center director Lewis Cantley has collaborated with fellow Breakthrough Prize award winners to establish a new annual life sciences award for postdocs. Read more
